0001127602-22-017244.txt : 20220610
0001127602-22-017244.hdr.sgml : 20220610
20220610164040
ACCESSION NUMBER: 0001127602-22-017244
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220608
FILED AS OF DATE: 20220610
DATE AS OF CHANGE: 20220610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vickers Philip J.
CENTRAL INDEX KEY: 0001635046
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38537
FILM NUMBER: 221009501
MAIL ADDRESS:
STREET 1: C/O REVANCE THERAPEUTICS, INC.
STREET 2: 7555 GATEWAY BOULEVARD
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVROBIO, Inc.
CENTRAL INDEX KEY: 0001681087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 810710585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 300, SUITE 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7819626030
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 300, SUITE 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AvroBio, Inc.
DATE OF NAME CHANGE: 20160729
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-06-08
0001681087
AVROBIO, Inc.
AVRO
0001635046
Vickers Philip J.
C/O AVROBIO, INC.
ONE KENDALL SQUARE, BLDG. 300, SUITE 201
CAMBRIDGE
MA
02139
1
Stock Option (Right to Buy)
1.06
2022-06-08
4
A
0
17478
0
A
2032-06-07
Common Stock
17478
17478
D
Stock Option (Right to Buy)
1.06
2022-06-08
4
A
0
17478
0
A
2032-06-07
Common Stock
17478
17478
D
The option shall vest in full upon the earlier of June 8, 2023 or the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date.
/s/ Christopher Gerry, Attorney in Fact for Philip J. Vickers
2022-06-10